Impact of Stigma in Siblings of Young Patients With Schizophrenic Disorders
NCT ID: NCT04411797
Last Updated: 2020-06-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
198 participants
OBSERVATIONAL
2020-05-25
2022-05-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Internalized Stigma in Patients With Bipolar Disorder or Schizophrenia
NCT01664884
Multi-site Communication Deficits in Schizophrenia
NCT01317121
Exploring the Effectiveness of Group Cognitive Stimulation Therapy in People With Schizophrenia.
NCT04916483
Social Functioning in Schizophrenia
NCT00814996
Tryptophan-Kynurenine Pathway Metabolism in the Pathophysiology of Cognitive Impairment in Schizophrenia.
NCT07162467
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Medical follow-up in progress
3. DSM-5 diagnosis of Schizophrenia Spectrum Disorder
4. Reading and understanding the information and non-opposition form
5. Person affiliated to a social protection scheme or beneficiary of State Medical Aid
6. Volunteer mastering the French language
1\. Clinical condition incompatible with testing 2. Current or less than one month's commitment to another research protocol 3. A person who is subject to a safeguard measure of justice 4 A person of full age under guardianship 5. Minor patients with mental disorders 6. Pregnant or breastfeeding women Version 1.2 date 19-05-2020 7. A person in situations of social fragility (persons deprived of liberty by a judicial or administrative decision, hospitalized persons) 8. Persons incapable or unable to give consent
1. Age of 16 years or older
2. Volunteer with a sibling included in the study with a diagnosis of schizophrenia according to DSM-5.
3. Reading and understanding the information and non-opposition form
4. Volunteer affiliated to a social protection scheme or beneficiary of State Medical Aid
5. Volunteer mastering the French language
Criteria for non-inclusion of siblings:
1. Clinical condition incompatible with testing
2. Current or less than one month's commitment to another research protocol
3. Brother or sister subject to a measure of safeguard of justice 4 Brother or sister under curatorship
5\. Brother or sister with mental health problems 6. Minor siblings under 16 years of age 7. A pregnant or nursing sister 8. Brother or sister in situations of social fragility (Persons deprived of liberty by a judicial or administrative decision, hospitalized persons) 9.Brother or sister incapable or unable to give consent
18 Years
35 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Januel
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Januel
Head of clinical research unit
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Davtian Hélène, Doctor
Role: PRINCIPAL_INVESTIGATOR
Les Funambules - Falret
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
10477M-STIG
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.